I R Macpherson - JoVE Visualize

Showing results (1-10 of 9) with videos related to

Pageof 1

Sort By:

ESMO Open|June 7, 2021

A review of the evidence base for utilizing Child-Pugh criteria for guiding dosing of anticancer drugs in patients with cancer and liver impairmentC Palmieri, I R Macpherson

Clinical Oncology (Royal College of Radiologists (Great Britain))|July 4, 2017

Neoadjuvant Therapy in Early Breast Cancer: Treatment Considerations and Common Debates in PracticeH Cain, I R Macpherson, M Beresford, et al.

Oncogene|March 6, 2007

p120-catenin is required for the collective invasion of squamous cell carcinoma cells via a phosphorylation-independent mechanismI R Macpherson, S Hooper, A Serrels, et al.

European Journal of Cancer (Oxford, England : 1990)|October 27, 2012

A phase 1 study of OSI-930 in combination with erlotinib in patients with advanced solid tumoursI R Macpherson, S Poondru, G R Simon, et al.

Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 9, 2015

A randomised trial of the cool pad pillow topper versus standard care for sleep disturbance and hot flushes in women on endocrine therapy for breast cancerR Marshall-McKenna, A Morrison, L Stirling, et al.

Clinical Oncology (Royal College of Radiologists (Great Britain))|December 10, 2019

Dynamic Changes in High-Sensitivity Cardiac Troponin I in Response to Anthracycline-Based ChemotherapyE Tzolos, P D Adamson, P S Hall, et al.

Nature Communications|June 10, 2022

Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancerR C Coombes, P D Badman, J P Lozano-Kuehne, et al.

Breast (Edinburgh, Scotland)|October 3, 2018

The presentation, management and outcome of inflammatory breast cancer cases in the UK: Data from a multi-centre retrospective reviewE Copson, A M Shaaban, T Maishman, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 24, 2022

Results of the c-TRAK TN trial: a clinical trial utilising ctDNA mutation tracking to detect molecular residual disease and trigger intervention in patients with moderate- and high-risk early-stage triple-negative breast cancerN C Turner, C Swift, B Jenkins, et al.

Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:

Pageof 1

ESMO Open|June 7, 2021

A review of the evidence base for utilizing Child-Pugh criteria for guiding dosing of anticancer drugs in patients with cancer and liver impairmentC Palmieri, I R Macpherson

Clinical Oncology (Royal College of Radiologists (Great Britain))|July 4, 2017

Neoadjuvant Therapy in Early Breast Cancer: Treatment Considerations and Common Debates in PracticeH Cain, I R Macpherson, M Beresford, et al.

Oncogene|March 6, 2007

p120-catenin is required for the collective invasion of squamous cell carcinoma cells via a phosphorylation-independent mechanismI R Macpherson, S Hooper, A Serrels, et al.

European Journal of Cancer (Oxford, England : 1990)|October 27, 2012

A phase 1 study of OSI-930 in combination with erlotinib in patients with advanced solid tumoursI R Macpherson, S Poondru, G R Simon, et al.

Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 9, 2015

A randomised trial of the cool pad pillow topper versus standard care for sleep disturbance and hot flushes in women on endocrine therapy for breast cancerR Marshall-McKenna, A Morrison, L Stirling, et al.

Clinical Oncology (Royal College of Radiologists (Great Britain))|December 10, 2019

Dynamic Changes in High-Sensitivity Cardiac Troponin I in Response to Anthracycline-Based ChemotherapyE Tzolos, P D Adamson, P S Hall, et al.

Nature Communications|June 10, 2022

Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancerR C Coombes, P D Badman, J P Lozano-Kuehne, et al.

Breast (Edinburgh, Scotland)|October 3, 2018

The presentation, management and outcome of inflammatory breast cancer cases in the UK: Data from a multi-centre retrospective reviewE Copson, A M Shaaban, T Maishman, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 24, 2022

Results of the c-TRAK TN trial: a clinical trial utilising ctDNA mutation tracking to detect molecular residual disease and trigger intervention in patients with moderate- and high-risk early-stage triple-negative breast cancerN C Turner, C Swift, B Jenkins, et al.

Pageof 1